ArticleOncoTargets and therapy2019

miR-762 Promotes Malignant Development of Head and Neck Squamous Cell Carcinoma by Targeting PHLPP2 and FOXO4.

Shuai Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.